Applied and Environmental Microbiology, August 1999, p. 3534-3539, Vol. 65, No. 8
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genomic Characterization of Human and Environmental
Polioviruses Isolated in Albania
Maurizio
Divizia,1,*
Leonardo
Palombi,1
Ersilia
Buonomo,1
Domenica
Donia,1
Vito
Ruscio,1
Michele
Equestre,2
Luljeta
Leno,3
Augusto
Panà,1 and
Anna Marta
Degener4
Faculty of Medicine, Department of Public
Health, University of Tor Vergata,1
Department of Cellular and Developmental Biology, University of
La Sapienza,4 and Laboratory of
Virology, High Institute of Public Health,2
Rome, Italy, and Institute of Public Health, Tirana,
Albania3
Received 1 March 1999/Accepted 19 May 1999
 |
ABSTRACT |
Between April and December 1996, a serious outbreak of
poliomyelitis occurred in Albania; almost 140 subjects were involved, and the episode presented an unusually high mortality rate (12%). During the outbreak, water samples from the Lana River in Tirana, Albania, and stool samples from two cases of paralytic poliomyelitis were collected and analyzed for the presence of polioviruses. Six
polioviruses were isolated from the environmental and human samples,
according to standard methods. All the samples were characterized by
partial genomic sequencing of 330 bases across the 5' untranslated region (5'-UTR) (nucleotide positions 200 to 530) and of 300 bases across the VP1 region (nucleotide positions 2474 to 2774). Comparison of these sequences with those present in data banks permitted the
identification of environmental isolates Lana A and Lana B as,
respectively, a Sabin-like type 2 poliovirus and an intertypic recombinant poliovirus (Sabin-like type 2/wild type 1), both bearing a
G instead of an A at nucleotide position 481. The two other environmental polioviruses were similar to the isolates from the paralytic cases. They were characterized by a peculiar 5'-UTR and by a
VP1 region showing 98% homology with the Albanian epidemic type 1 isolates reported by other authors. This study confirms the
environmental circulation in Albania of recombinant poliovirus strains,
likely sustained by a massive vaccination effort and by the presence in
the environment of a type 1 poliovirus, as isolated from the Lana River
in Tirana about 2 months before the first case of symptomatic acute
flaccid paralysis was reported in this town.
 |
INTRODUCTION |
The strategy for the global
eradication of poliovirus requires an effective immunization program,
an accurate environmental surveillance and assiduous epidemiological
investigation program to monitor the circulation of wild and vaccine
strains, and an increasing attention to aspects of policy, such as the
recommendations of the World Health Organization's International
Office, in order to reduce the risk of adverse events following
immunization (27). In 1988, the World Health Assembly
projected the global eradication of poliomyelitis by the year 2000. Meanwhile, national immunization days were conducted in 65 countries in
1995, reaching 300 million children. Reported cases of poliomyelitis
declined from 32,351 cases in 1988 to 7,024 in 1995 (6), and
the complete eradication of the disease is now expected by 2005.
Despite improvements globally, the control of poliomyelitis in the
Balkan area has been interrupted by bounded outbreaks, the most recent
of which occurred in 1990 and 1991 in the Central Asian Republics and
Central and Eastern Europe (the former Soviet Union) (22,
25). In 1996, a large outbreak occurred in Albania, resulting in
138 paralytic cases scattered throughout 27 districts of the country
(10). This outbreak appears to be tied to a low level of
immunity in the general population, poor personal hygiene in crowded
families, and incorrect sewage disposal. More than 140,000 diarrheal
diseases occur each year in Albania, and 10% of all the deaths of
children under 5 years old are caused by diarrhea; at the moment, only
70% of the urban and 36% of the rural population of Albania has
access to purified drinking water (26).
It has been demonstrated that inter- and intratypic recombination among
different strains of poliovirus is frequent in vivo (5). The
genetic variability affecting the RNA genome of the Sabin strains
induces reversion towards those neurovirulent phenotypes mainly
responsible for vaccine-associated paralytic poliomyelitis (VAPP),
which is frequently associated with type 2 and type 3 strains of
poliovirus and is seldom associated with type 1 viruses. Sabin
poliovirus replication in the human gut could lead to reversions of the
vaccine strains to pathogenic phenotypes by recombination during mixed
in vivo infections (16). Events of recombination are
relatively frequent for type 3 polioviruses, whereas types 2 and 1 are
more stable (5, 12). Recently, Guillot et al. (14) have shown that several VAPP-causing strains classified as possible Sabin revertants were recombinations between wild-type and
Sabin strains.
During the 1996 outbreak, personnel of the Hygiene Institute in Tirana
had the opportunity to collect superficial water from the Lana River
where it flows through Tirana. Four polioviruses were isolated from the
environment, and two others were obtained from stool samples collected
from people suffering from acute flaccid paralysis (AFP). Sequence
analysis of the 330-bp amplicons originating from the 5' untranslated
region (5'-UTR) and from the 300-bp VP1 portion of the genomes
classified the environmental isolate Lana B as an intertypic
recombinant between the Sabin-like type 2 sequence tract furthest
upstream and the wild-type type 1 sequence tract furthest downstream.
The same method of sequence analysis for Lana A showed a 96% genetic
similarity to the poliovirus type 2 Sabin strain (P712,ch,2ab),
including the A
G mutation at nucleotide (nt) 481. The two other
polioviruses (Lana C and D) and the two viruses isolated from human
cases were similar, showing a VP1 region genetically linked to that of
other type 1 Albanian isolates (10).
 |
MATERIALS AND METHODS |
Water sample.
Ten liters of superficial water from the Lana
River in Tirana was collected and processed in two steps. The first
step was performed in Albania. The sample was prefiltered through
several layers of sterile gauze and ultraconcentrated by a Prep-scale ultrafiltration apparatus (Millipore) using a PTHL, 6-ft-2-in., 100,000-Da cutoff cartridge in polyethersulfone. The cartridge was
washed with 5 liters of distilled water and preconditioned by filtering
500 ml of 3% beef extract, pH 7.0. The sample was concentrated at 1 lb/in2 income pressure, and the ultrafiltration stopped
when the final volume of the sample reached 1.0 to 1.5 liters. The
cartridge was completely emptied and washed with 100 to 120 ml of beef
extract, pH 9.5. The ultraconcentrated sample and the washing buffer
were collected together, the pH was adjusted to 7.0 to 7.2, and the mixture was frozen to be sent to Italy for the second step of processing. In Italy, the sample was reconcentrated by a similar ultrafiltration apparatus but using a smaller, PTHK, 1-ft-2-in., 100,000-Da cutoff cartridge in polyethersulfone. The sample was processed as before, and the final volume was less than 200 ml, including the 40 to 50 ml of washing buffer. The ultraconcentrated sample was reconcentrated by the polyethylene glycol 6000 precipitation, according to the method of Lewis and Metcalf
(18), and the pellet was resuspended in 5 to 10 ml of
sterile phosphate-buffered saline.
Poliovirus isolation by plaque assay.
Each sample was
extracted twice with 30% chloroform, and the interface was extracted
with 200 to 400 µl of cell culture media without fetal calf serum.
The aqueous phases were collected together and added to a 20× solution
of antibiotics (penicillin G, 100,000 U/ml; streptomycin, 120 mg/ml;
kanamycin, 10 mg/ml; nystatin, 3.2 mg/ml) which was diluted at the time
of the experiment. After 2 h at 37°C in a water bath, the sample
was neutralized by using a mixture of polyclonal antibodies against all
the known enteroviruses except for poliovirus (National Institute of
Public Health and Environmental Hygiene, Bilthoven, The Netherlands)
and kept for 2 h at 37°C in a water bath. An aliquot of the
treated sample was used to infect a 2-day-old culture of Buffalo green
monkey (BGM) cells, grown in a 90-mm-diameter petri dish. After 2 h at 37°C in a 5% CO2 atmosphere, the inoculum was
discharged, and approximately 25 to 30 ml of minimum essential medium
with Earle salts containing 2% fetal calf serum and 50% agar was
added. The petri dishes were observed each day, and the single plaque
was picked out and used to infect a 2-day-old monolayer growth in a
25-cm2 Falcon flask. When a complete cytopathic effect was
observed, the flasks were frozen at
80°C. The presence of the virus
was confirmed by a second passage on a 2-day-old monolayer of BGM cells, and individual viruses were classified as Lana A through D.
Virus isolation from patients.
Two polioviruses isolated
from cases of AFP, collected in two distinct districts of Albania
(Durres and Berat), were obtained directly from the Hygiene Institute
in Tirana. The stool samples were collected in the first week after the
patients were hospitalized, and the samples were passaged once on
2-day-old BGM cells. The cells were frozen at
80°C after a complete
cytopathic effect was observed.
Genomic RNA extraction and RT-PCR test.
The supernatants of
infected and mock-infected cells were clarified by low-speed
centrifugation (1,400 × g for 15 min), and 100 µl of
clarified supernatant was extracted by using a commercial kit based on
the guanidinium thiocyanate method (Ultraspec; Bioteck). The RNA pellet
was resuspended in 18 µl of nuclease-free water. Six microliters of
RNA was combined with 4 µl of a universal buffer for reverse
transcription (RT) (Promega), 1 µl of 50 mM random primer
(Perkin-Elmer), 5 µl of water, and 0.8 µl of deoxynucleoside triphosphate (dNTP) at 100 mM (Promega), and the mixture was boiled at
95°C for 5 min and immediately placed in ice for at least 5 min. The
RT step was performed by adding 7.4 µl of water, 20 U of RNasin
(Promega), 4 U of avian leukosis virus reverse transcriptase (Promega),
and water to a final volume of 20 µl. After 10 min at room
temperature, the mixture was placed in a water bath at 37°C for
1 h. The first round of PCR was performed by using 5 µl of cDNA
and 95 µl of a mixture containing 10 µl of 10× PCR buffer
(Promega), 10 mM each dNTP (Promega), 4 U of Taq polymerase (Promega), 50 pmol each of sense and antisense primer, and water to a
final volume of 100 µl per reaction. A nested PCR was performed for
only the VP1 region in a 100-µl reaction volume by using 5 µl of
the first PCR product in the same buffer as above but using internal
sense and antisense primers. Negative and positive controls were
included in each assay, and PCR products were electrophoresed through a
2% agarose gel in Tris-acetate-EDTA (TAE) buffer containing ethidium
bromide. In the above PCRs, the cycles used were as follows: 2 min at
95°C; 30 cycles at 94°C for 1 min, 45°C for 1 min, and 72°C for
2 min; and a final elongation step at 72°C for 7 min. The primers
used for the VP1 region were as follows (according to the nucleotide
numbers of the wild-type poliovirus P1/Mahoney; accession no. V01149):
external primers, nt 2402 to 2422 and nt 2881 to 2861 (3);
internal primers, nt 2426 to 2446 and nt 2812 to 2792; and for 5'
noncoding region, nt 160 to 180 and nt 599 to 580.
Nucleotide sequence determination.
Before sequencing, PCR
products were purified by using a QIAquick column purification kit
(Genenco) according to the manufacturer's instructions. DNA sequencing
was performed by the cycle sequencing method (Amplicycle kit;
Perkin-Elmer) and by automatic DNA sequencing (Applied Biosystem model
37OA; Perkin-Elmer). In the latter procedure, about 500 ng of PCR
product DNA and 0.8 pmol of one of the same primers used in the
amplification reaction were employed in each sequencing reaction. Both
strands of the amplified fragments were sequenced to confirm the nature
of the product obtained.
Data analysis.
Sequence data were analyzed and compared to
the accessible sequence data banks by the Genetics Computer Group
(7) and BLAST software packages (1). Multiple
alignments were performed by the CLUSTAL V program (15).
Sequence relatedness between the reference strains and our isolates was
analyzed by distance-determining methods provided by the PHYLIP
software package (9). The Expect values are also reported
(an Expect value is a BLAST indicator determining the statistical
significance of the number of alignments found and indicates the number
of times one might expect to see such a match merely by chance). The
lower the Expect value, the better is the match. The reference strains
introduced into the analysis were as follows:
gi/3334777-8-9/emb/AJ00796-7-8/POV7966-7-8, gi/61252/emb/V01149/POLIO1B (P1/Mahoney),
gb/L76402/POL5UTRF-15/Hong Kong/81, gi/61257/emb/V01150/POLIOS1
(P1/Sabin), gi/61127/emb/X00595/PIPOLS2 (P2/Sabin, P712,ch,2ab),
gi/61114/emb/X01076/PIPO3119 (P3/119), gi/332895/emb/K01392/POL3L37
(P3L37), and gb/L76413/POL5-UTRN-50/URSS/87.
 |
RESULTS AND DISCUSSION |
During the outbreak, in June 1996 and 2 months before the first
case of AFP was detected in Tirana, water samples from the Lana River
in Tirana were collected and partially concentrated at the Hygiene
Institute of Tirana. The sampling point for all the withdrawals was the
same. The preliminary assay for cultivable enteroviruses showed a viral
concentration of 103 to 104 PFU/liter. It has
to be emphasized that the Lana River collects not only superficial and
rain waters but also untreated wastewater from Tirana and its suburbs.
Furthermore, each year in Albania, more than 140,000 people are
hospitalized with gastroenteritis. In the same period, the Hygiene
Institute of Tirana sent us two unclassifiable polioviruses isolated
from two cases of AFP. The first case involved a 22-year-old subject
vaccinated with monovalent oral vaccine, and the second case involved a
17-year-old subject vaccinated with trivalent oral vaccine. Both
subjects received several doses of vaccine. The extraction of isolated
genomic RNAs was successfully achieved by using the Ultraspec kit
(Bioteck), based on guanidium isothiocyanate. Intratypic
differentiation of human and environmental polioviruses by restriction
fragment length polymorphism assays was abandoned due to the difficulty of amplifying genome isolates in RT-PCRs driven by the primers previously described (11). Therefore, we reinforced the
yield of amplicons by nested PCR by using another set of primers to amplify the same portion of the genome, extending from nt 2426 to 2812. Another amplicon of the genome region extending into the 5'-UTR from nt
160 to 599, produced in order to read nt 480, 481 and 472, indicated
the presence of markers of attenuation for vaccine strains type 1, 2, and 3, respectively. Automated sequence analyses were performed
according to standard methods. Figure 1
shows the sequence alignment of 5'-UTRs from wild-type, vaccine
poliovirus reference strains and the corresponding regions of our
isolates. Among the environmental isolates, Lana A showed a 96%
genetic similarity to P712,ch,2ab with a mutation at nt 481 (A
G).
The two other viruses isolated from the environment (Lana C and D) and
the two viruses isolated from cases of AFP showed almost the same
nucleotide sequence (98% homology). At the same time, when submitted
to the accessible data banks, these viruses revealed 5'-UTR sequences
peculiarly homologous for type 3 and type 1 AFP isolates. The isolate
sequences showed the highest level of statistical significance (i.e.,
had the lowest Expect value as calculated by the BLAST program
[17]) for the type 3 isolate
gb/L76413/POL-5UTRN-50/URSS/87 (Expect value: e
128) and
showed a lower statistical significance for the isolate gb/L76402/POL5UTRF-15/Hong Kong/81 (Expect value: e
113)
(Fig. 1). For the next lowest score, we have to move downward to an
Expect value of 8e
94, identified by other poliovirus
serotypes. At nt 480 and 472, our isolates carried bases A and C,
respectively, characteristic of wild-type strains 1 and 3. According to
the sequence comparison of 5'-UTRs shown in Fig. 1, it is not possible
to definitely link isolates Lana C, Lana D, AFP6, and AFP8 to an
independent poliovirus strain or to link them with certainty to
country-circulating strains, because of the exiguity of 5'-UTR
sequences present in the accessible data banks despite the large number
of isolates reported in the literature from the many epidemics which
have occurred in the Central Asian Republics and Central and Eastern
Europe. For conciseness, the 5'-UTR sequences of human isolates AFP6
and AFP8 are not reported in the sequence alignment shown in Fig. 1
because they were identical to isolates Lana C and Lana D, except for a
T
C transition at nt 375 and an A
C transversion at nt 435. This
identity between environmental and human isolates, despite their
isolation from geographically distinct areas, indicates a common viral
source.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide differences among reference strains of all
three serotypes and the isolates from this study. The reverted bases
characteristic of each serotype are shown (boldface) and numbered
(within parentheses) according to the relative reference numeration.
|
|
To further define our isolates at the molecular level, we
compared the sequences of their 300-nt VP1 regions (nt 2474 to 2774) with those of other strains related to the Albanian outbreak
(10) and with those of the wild and vaccine reference
strains. In Fig. 2, the nucleotide
alignment of the mentioned sequences shows 99% homology between Lana A
and P712,ch,2ab with three nucleotide substitutions resulting in
synonymous codons, thus yielding the total amino acid identity between
the two sequences. The other environmental isolates, Lana B, Lana C,
and Lana D, as well as the two human isolates, AFP6 and AFP8, showed
98% nucleotide homology (Expect value: e
154), with the
type 1 POV796/7/8/9 (data bank entry). As shown in Fig. 2, the
percentage of nucleotide homology between Lana B, C, and D, AFP6/8, and
the wild, type 1 Mahoney reference strain consistently decreases to
80% (Expect value: 8e
23). Most of these nucleotide
mutations resulted in synonymous codons. Therefore, seven amino acid
changes (polyprotein amino acids: nt 599, A
S; nt 610, A
S; nt 614, T
A; nt 645, V
I; nt 673, P
S; nt 678, N
S; and nt 684, A
S)
characterized 95% amino acid homology with the Mahoney reference
strain. Lana B accumulated three further amino acid substitutions (nt
643, H
L; nt 664, C
W; and nt 665, V
L). In this regard, it has
to be said that Lana B has been finally characterized as a recombinant
Sabin-like type 2/wild-type 1 poliovirus (in 5'-UTR and VP1 regions,
respectively) that presumably challenged the forces of selection in a
such a way as to induce a genetic variation different than that of the
original wild-type strain.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of 278-nt region (nt 2532 to 2810) coding for
VP1. The comparison is with gi/61252/emb/V01149/POLIO1B,
gi/61257/emb/V01150/POLIOS1,
gi/3334777-8-9/emb/AJ00796-7-8/POV7966-7-8, and
gi/61127/emb/X00595/PIPOLS2.
|
|
We also generated a dendrogram of the nucleotide sequence relationship
between the isolates examined in this study (Fig.
3). The three branches represent
essentially different genotypes that diverge by more than 15% and form
groups composed of the type 2 Sabin strain, the environmental and human
Albanian isolates, and poliovirus type 1 reference strains,
respectively. Conversely, the high percentage of genetic identity
within each cluster could account for a direct transmission linkage
between different isolates.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
Dendrogram showing sequence relationship among Albanian
isolates and data bank reference strains. The tree is based on 278 nt
of the VP1-coding region. Pol1Sab, poliovirus type 1 strain Sabin;
Pol1Mah, poliovirus type 1 strain Mahoney; PIPOLS2VP1, poliovirus type
2 strain Sabin; POV7966, -7, -8, -9, human poliovirus cases from
Albania (10); AFP6 and -8, human poliovirus cases (this
study); LanaA, -B, -C, and -D, environmental poliovirus isolated from
the Lana River (this study).
|
|
To summarize, for the environmental isolate Lana A, the sequence
analysis of both the 5'-UTR and VP1 regions showed 96% genetic similarity to the poliovirus type 2 Sabin strain, including an A
G
mutation at nt 481. Furthermore, the mutations observed in the VP1
region of Lana A were silent, producing a protein identical to that
produced by reference strain P712,ch,2ab, thus undoubtedly characterizing it as a Sabin-like poliovirus. Interestingly, the characterization of the environmental isolate Lana B defined a recombinant genome showing a 5'-UTR region identical to that of P712,ch,2ab except for nt 481 (which was G, as in the wild type) and a
portion of the VP1 sequence which showed 98% homology with the
type 1 strains isolated from humans in Albania reported by Fiore et al.
(10) and 80% homology with the Mahoney type 1 poliovirus. All the other isolates were strongly linked by their VP1 regions to the type 1 strains isolated in the Albanian epidemics by Fiore et
al. (10). The 5'-UTRs of those isolates were characterized by a pattern of similarity with the poliovirus sequences
gb/L76413/POL5-UTRN-50/URSS/87 and
gb/L76402/POL5UTRF-15/Hong Kong/81 peculiar among the
sequences contained in the accessible data banks.
The outbreak of poliomyelitis started in May 1996 with the diagnosis of
a 1-year-old child (VAPP; index case), 10 days after the first local,
oral, vaccine dose. Almost 1 month later, three other human cases were
identified in three different districts. A total of 138 cases were
officially reported, and the mortality rate was unusually high: 12%.
The paralytic poliomyelitis in Albania has been described in its
epidemiological aspects by Prevots et al. (20). The index
case was in the district of Lac, whereas the other three cases (in 2-, 29-, and 30-year-old subjects) were identified in three different
districts located far away from the index case and each other. Albania
is considered to be the poorest country in Europe, and, due to the
present economic and health situations in that country, a constant
massive movement of people from the rural and mountainous regions
towards the coast is in evidence. In the rural areas, a high percentage
(23.6%) of children are underweight in comparison with the children in urban areas (10.2%) (4). Consequently, the direction of
migration is always from the country's inner, mountainous regions
towards the seaside of the country, which includes the country's main cities. From an epidemiological point of view, the outbreak of poliomyelitis appears to have a multifocal origin, a view confirmed by
the appearance in May of other cases of poliomyelitis in areas distant
from the sites of the initial three cases. In July, the outbreak
involved three large areas of the country, with a higher number of AFP
diagnoses being made in the country's northeast regions (mountain
districts). During the following months, the three areas were
confluent, and 27 of Albania's 36 districts presented cases of AFP
(Fig. 4). The cause of this outbreak was
the low level of immunity of the people, as shown by Squarcione et al. (21), who found high levels of seronegativity towards one or more polioviruses in a large group of Albanian refugees. In particular, the seronegativity reached 40% for poliovirus type 3 and around 20%
for poliovirus types 1 and 2. These data are in good agreement with the
data reported from other developing countries. Several factors can
determine this negative result: the low level of immunogenicity of the
vaccine, the vaccination escape, the absence of a "cold chain" to
avoid vaccine inactivation, the copresence of other enteric viruses in
the gut, etc. Triki et al. (24) have documented that the
only host-related factor of the antibody response toward the polio
vaccine was the presence of other enteric viruses. In fact, infection
with other enteric viruses can cause a state of diarrhea in which the
mucosal structure of the infected person is altered, and, consequently,
a more rapid clearance of the gastrointestinal tract and a reduced
poliovirus immunization can occur (19). The mean age of the
people suffering from AFP was 21, and this group included subjects
vaccinated during the 1960s and 1970s with monovalent oral poliovirus
vaccine by receiving just two doses of vaccine produced directly in
Albania. Strebel et al. (22), analyzing cases of paralytic
poliomyelitis in Romania, have shown that cases of VAPP were not
influenced by a change in oral poliovirus vaccine manufacturers.
Studies conducted in industrialized countries have shown 100%
seroconversion in vaccinated infants, whereas the seroconversion rate
is lower in developing countries, particularly for poliovirus types 3 and 1 (23). These data confirm those obtained by Green et
al. (13), who found different levels of seroconversion in
young adults involved in a 1988 outbreak in Israel. The appearance of
different immunogenic strains of poliovirus in a country has been
documented. Hovi et al. (16) described the appearance of a
new variant of poliovirus type 3 which differed from the type 3 vaccine
strains in both immunological and molecular characteristics; not much
information about poliovirus strains in Albania is available, with the
exception of strains isolated in the large outbreaks before the 1980s.
From the early 1980s until 1995, only cases of VAPP have been reported, and no wild poliovirus has been isolated (8). Green et al. (13) have documented that the poliovirus involved in the
1988 outbreak in Israel was the descendant of a wild poliovirus present in Israel and Jordan since the early 1980s. In Albania, a complete surveillance system and maintenance of poliovaccine were organized by
the World Health Organization only in the early 1990s.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Poliomyelitis case distribution in Albania. , index
case; numbers, number of poliomyelitis cases reported in the
district.
|
|
Our data confirm the data from Green et al. (13) showing the
presence of wild poliovirus types 1 and 3 (gb/L76413/POL5-UTRN-50/URSS/87) in a particular area of Albania.
Almost 700,000 doses of trivalent oral vaccine were distributed from
May to June 1996, ensuring a large circulation of attenuated poliovirus
in a country where the presence of poliovirus in previous years could
be suspected. The possible rearrangement of poliovirus with
still-present wild types has been well documented by Cammack et al.
(5), and such rearrangement has been reported in an outbreak
in Finland (16). This rearrangement event also appears to be
a possible cause of the epidemic in Albania. It would be advisable to
elaborate new immunization strategies for isolated and not regularly
checked populations. In order to reduce cases of VAPP, preference
should be given to the use of inactivated poliovirus vaccine, alone or
followed by the oral vaccine, as recommended by the American Academy of
Pediatrics (2).
 |
ACKNOWLEDGMENTS |
This investigation was developed under the "Control of
Diarrhoea Diseases including Cholera" emergency program founded by UNICEF and the Italian Ministry of Foreign Affairs, and this work was
supported by the Community of St. Egidio nongovernmental organization.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Tor Vergata, Faculty of Medicine, Department of Public Health, Chair of
Hygiene, Via di Tor Vergata, 135, 00133 Rome, Italy. Phone: 39/06/72596119. Fax: 39/06/2025285. E-mail:
divizia{at}med.uniroma2.it.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped blast and PSI-Blast: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 2.
|
American Academy of Pediatrics Committee on Infectious Diseases.
1999.
Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines.
Pediatrics
103:171-172[Abstract/Free Full Text].
|
| 3.
|
Balanant, J.,
S. Guillot,
A. Candrea,
F. Delpeyroux, and R. Crainic.
1991.
The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.
Virology
184:645-654[Medline].
|
| 4.
|
Buonomo, E.,
M. C. Marazzi,
S. Mancinelli,
D. Hoxha,
F. Cenko, and L. Palombi.
1998.
Infant nutritional and health status, feeding practices in rural and urban Albania.
Ann. Ig.
10:163-171[Medline].
|
| 5.
|
Cammack, N.,
A. Phillis,
G. Dunn,
V. Patel, and P. D. Minor.
1988.
Intertypic genomic rearrangement of poliovirus strains in vaccinees.
Virology
167:507-514[Medline].
|
| 6.
|
Cochi, S. L.,
H. F. Hull,
R. W. Sutter,
C. M. Wilfert, and S. L. Katz.
1997.
Commentary: the unfolding story of global poliomyelitis eradication.
J. Infect. Dis.
175(Suppl. 1):S1-S3.
|
| 7.
|
Devereaux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the Vax.
Nucleic Acids Res.
12:387-395.
|
| 8.
|
Diamanti, E.,
B. Ibrahimi,
F. Tafaj,
E. Mezini,
A. Dodbiba,
V. Dobi,
S. Catone,
D. Genovese,
P. Simeoni, and L. Fiore.
1998.
Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.
Vaccine
16:940-948[Medline].
|
| 9.
|
Felsenstein, J.
1981.
Evolution trees from DNA sequences: a maximum likelihood approach.
J. Mol. Evol.
17:368-376[Medline].
|
| 10.
|
Fiore, L.,
D. Genovese,
E. Diamanti,
S. Catone,
B. Ridolfi,
B. Ibrahimi,
R. Konomi,
H. G. A. M. Van der Avoort,
T. Hovi,
R. Crainic,
P. Simeoni, and C. Amato.
1998.
Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996.
J. Clin. Microbiol.
36:1912-1918[Abstract/Free Full Text].
|
| 11.
|
Furione, M.,
S. Guillot,
D. Otelea,
J. Balanant,
A. Candrea, and R. Crainic.
1993.
Poliovirus with natural recombination genomes isolated from vaccine-associated paralytic poliomyelitis.
Virology
196:113-120.
|
| 12.
|
Georgescu, M. M.,
F. Delpeyroux, and R. Crainic.
1995.
Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
J. Gen. Virol.
76:2343-2348[Abstract/Free Full Text].
|
| 13.
|
Green, M. S.,
R. Handsher,
D. Cohen,
J. L. Melnik,
R. Slepon,
E. Mendelsohn, and Y. L. Danon.
1993.
Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
Vaccine
11:75-81[Medline].
|
| 14.
|
Guillot, S.,
V. Caro,
G. Dahourou,
N. Cuervo,
J. Balanant,
F. Delpeyroux, and R. Crainic.
1998.
Looking for parents of the vaccine/wild (V/W) poliovirus recombinants. Presented at the 10th meeting of the European study group on the molecular biology of picornaviruses. Jena, Germany, 5 to 11 September 1998
.
|
| 15.
|
Higgins, D. G., and P. M. Sharp.
1988.
Clustal: a package for performing multiple sequence alignment on a microcomputer.
Gene
73:237-244[Medline].
|
| 16.
|
Hovi, T.,
A. Huovilainen,
T. Kuronen,
T. Poyry,
N. Salama,
K. Cantell,
E. Kinnunen,
K. Lapinleimu,
M. Roivainen,
M. Stenvik,
A. Silander,
C. J. Thoden,
S. Salminen, and P. Weckstrom.
1986.
Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically alterated poliovirus type 3 in a vaccinated population.
Lancet
21:1427-1432.
|
| 17.
|
Karlin, S., and S. F. Altschul.
1993.
Applications and statistics for multiple high-scoring segments in molecular sequences.
Proc. Natl. Acad. Sci. USA
90:5873-5877[Abstract/Free Full Text].
|
| 18.
|
Lewis, G. D., and T. G. Metcalf.
1988.
Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus from oyster, water, and sediment samples.
Appl. Environ. Microbiol.
54:1983-1988[Abstract/Free Full Text].
|
| 19.
|
Patriarca, P. A.,
P. F. Wright, and J. T. Jacob.
1991.
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries.
Rev. Infect. Dis.
13:926-939[Medline].
|
| 20.
|
Prevots, D. R.,
M. L. Ciofi degli Atti,
A. Sallabanda,
E. Diamanti,
R. B. Aylward,
E. Kakariqqi,
L. Fiore,
A. Ylli,
H. Van der Avoort,
R. W. Sutter,
A. E. Tozzi,
P. Panei,
N. Schinaia,
D. Genovese,
G. Oblapenko,
D. Greco, and S. G. F. Wassilak.
1998.
Outbreak of paralytic poliomyelitis in Albania 1966: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.
Clin. Infect. Dis.
26:419-425[Medline].
|
| 21.
|
Squarcione, S.,
C. Germinario,
E. Iandolo,
S. Lo Caputo,
F. Bergamini,
M. L. Profeta,
D. Greco,
M. Quarto, and S. Barbuti.
1992.
Seroimmunity to poliomyelitis in an Albanian immigrant population.
Vaccine
10:853-856[Medline].
|
| 22.
|
Strebel, P. M.,
A. Aubert-Combiescu,
N. Ion-Nedelcu,
S. Biberi-Moroeanu,
M. Combiescu,
R. W. Sutter,
O. M. Kew,
M. A. Pallansch,
P. A. Patriarca, and S. L. Cochi.
1994.
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
Am. J. Epidemiol.
140:1111-1124[Abstract/Free Full Text].
|
| 23.
|
Sutter, R. W.,
P. A. Patriarca,
A. J. M. Suleiman,
M. A. Pallansch,
E. R. Zell,
P. G. Malankar,
S. Brogan,
A. A. K. Al-Ghassani, and M. S. El-Bualy.
1993.
Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.
Int. J. Epidemiol.
22:936-944[Abstract/Free Full Text].
|
| 24.
|
Triki, H.,
M. V. Ould Mohamed,
R. Ben Aissa,
A. Bouratbine,
M. Ben Ali Kamec,
S. Bouraoui,
C. Koubaa,
S. Zouari,
E. Mohsni,
R. Crainic, and K. Dellagi.
1997.
Influence of host related factors on the antibody response to trivalent oral poliovaccine in Tunisian infants.
Vaccine
15:1123-1129[Medline].
|
| 25.
|
World Health Organization.
1992.
Expanded programme on immunization. Poliomyelitis outbreak, Bulgaria.
Weekly Epidemiol. Rec.
67:336-337[Medline].
|
| 26.
|
World Health Organization.
1995.
European centre for environment and health: concern for Europe's tomorrow.
World Health Organization, Stuttgart, Germany.
|
| 27.
|
World Health Organization.
1997.
Surveillance of adverse events following immunisation.
World Health Organization, Geneva, Switzerland.
|
Applied and Environmental Microbiology, August 1999, p. 3534-3539, Vol. 65, No. 8
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.